Demo Data from EDBT 2026 / reviewers in the wild / expert
Shihyung Park
dblp:432/6183
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2026
0009-0007-1529-5728ORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Databases, data management, data science and information retrieval · 1 · 1 since 2021Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Databases, data mining, and information retrieval
1 paper |
Machine learning and data management · 100% | |
| Artificial intelligence
1 paper |
Graph learning · 100% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Machine learning › Graph learning
graph classification |
1.0 | 1 | 2026 | Dual-level Reweighting for Positive-Unlabeled Graph Classification · WWW 2026 |
Machine learning and data management › weak supervision
positive-unlabeled learning |
1.0 | 1 | 2026 | Dual-level Reweighting for Positive-Unlabeled Graph Classification · WWW 2026 |
Machine learning and data management
weak supervision |
1.0 | 1 | 2026 | Dual-level Reweighting for Positive-Unlabeled Graph Classification · WWW 2026 |
Methods — techniques the papers use, named apart from their topics
graph pooling · 2.0dual reweighting · 2.0
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2026 | Dual-level Reweighting for Positive-Unlabeled Graph ClassificationabstractHow can we accurately classify graphs using only positive and unlabeled instances? This setting commonly arises in real-world tasks. For example, in drug side effect prediction, each drug is represented as a graph based on its chemical structure, and only those observed to cause adverse effects are labeled as positive. The remaining drugs are left unlabeled—not because they are confirmed safe, but because such side effects have not yet been discovered or reported. A challenge is that positive and negative graphs often share similar substructures, making it difficult for models to capture the subtle structural differences that distinguish true positives among unlabeled ones. This difficulty is further exacerbated by the absence of explicit negative labels, which leaves the model without clear guidance on how to separate informative from non-informative patterns. We propose Delta-PU, an accurate method for PU graph classification. Delta-PU performs dual reweighting: hop-level reweighting to emphasize informative substructures during pooling, and graph-level reweighting to suppress ambiguous unlabeled graphs. This dual mechanism allows the model to progressively focus on discriminative patterns while reducing the uncertainty introduced by unlabeled instances. Extensive experiments demonstrate that Delta-PU achieves the state-of-the-art performance in PU graph classification. Junghun Kim, Shihyung Park, U Kang |
WWW | 2 |